Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.760
+0.040 (2.33%)
At close: Feb 6, 2026, 4:00 PM EST
1.780
+0.020 (1.14%)
After-hours: Feb 6, 2026, 7:54 PM EST

Milestone Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--1515-
Revenue Growth (YoY)
---80.00%-66.67%--
Gross Profit
--1515-
Selling, General & Admin
40.727.7531.0524.8119.416.22
Research & Development
16.5314.3631.0539.8338.6734.49
Operating Expenses
57.2342.162.164.6458.0750.71
Operating Income
-57.23-42.1-61.1-59.64-43.07-50.71
Interest Expense
-3.77-3.58-2.55---
Interest & Investment Income
2.994.163.971.250.220.73
Pretax Income
-58.01-41.52-59.69-58.39-42.85-49.98
Income Tax Expense
------0.02
Net Income
-58.01-41.52-59.69-58.39-42.85-49.97
Net Income to Common
-58.01-41.52-59.69-58.39-42.85-49.97
Shares Outstanding (Basic)
746243424229
Shares Outstanding (Diluted)
746243424229
Shares Change (YoY)
31.08%44.82%1.19%1.47%42.56%85.91%
EPS (Basic)
-0.78-0.67-1.39-1.38-1.02-1.70
EPS (Diluted)
-0.78-0.67-1.39-1.38-1.02-1.70
Free Cash Flow
-43.15-28.88-46.54-52.74-33.22-50.73
Free Cash Flow Per Share
-0.58-0.46-1.08-1.24-0.79-1.73
Gross Margin
--100.00%100.00%100.00%-
Operating Margin
---6109.80%-1192.84%-287.15%-
Profit Margin
---5968.50%-1167.76%-285.69%-
Free Cash Flow Margin
---4653.60%-1054.82%-221.49%-
EBITDA
-57.13-42-61.01-59.55-42.98-50.61
EBITDA Margin
-----286.53%-
D&A For EBITDA
0.110.110.090.090.090.1
EBIT
-57.23-42.1-61.1-59.64-43.07-50.71
EBIT Margin
-----287.15%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q